2018 annual financial data

China SXT Pharmaceuticals 2018 Net margin

China SXT Pharmaceuticals 2018 net margin with verified reported values.

Direct answer

Net margin was 16.92%.

Operating income was 1,632,266 USD and net income was 1,187,581 USD.
Operating cash flow was 1,920,161 USD.

Get free China SXT Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
7,019,243 USD
Operating income
1,632,266 USD
Net income
1,187,581 USD
Operating cash flow
1,920,161 USD